NACL Industries Approves Q1 FY27 Results and Divestment of Associate
NACL Industries Limited's Board of Directors met on July 22, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The board also approved the sale of its entire equity stake in Nasense Labs Private Limited, an associate company, to Mr. Kanumuru Satyanarayana Raju for ₹8.15 crore. This divestment is expected to be completed within three months. Additionally, the board approved the Statement of Deviation(s) and Variation(s) and the Monitoring Agency Report concerning the utilization of funds from a December 2025 rights issue.
Key Highlights
- Approved Q1 FY27 unaudited standalone and consolidated financial results.
- Agreed to sell entire stake in Nasense Labs Private Limited for ₹8.15 crore.
- Divestment of associate company expected within three months.
- Reviewed utilization of funds from December 2025 rights issue.
Price Impact
More from NACLIND
NACL Industries Executes Share Purchase Agreement for Associate Stake Sale
NACL Industries Reports Nil Deviation in Rights Issue Fund Utilization
NACL Industries Ltd: Voting Results for FY26 Financial Statements and Director Re-appointment